ELOXX PHARMACEUTICALS, INC. Cash and Cash Equivalents
ELOXX PHARMACEUTICALS, INC. (ELOX) had Cash and Cash Equivalents of $61.96 million as of 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-09-11
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $61.96M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $6.36M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $4.79M.
- 2025-12-12: Cash and Cash Equivalents, at Carrying Value $4.80M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $61.96M S-1 · filed 2026-09-11 | |
| 2026-03-31 | $6.36M S-1/A · filed 2026-06-04 | |
| 2025-12-31 | $4.79M S-1 · filed 2026-09-11 | |
| 2025-12-12 | $4.80M S-1 · filed 2026-09-11 | |
| 2025-06-30 | $572.00K S-1 · filed 2026-09-11 | |
| 2025-03-31 | $450.00K S-1/A · filed 2026-06-04 | |
| 2024-12-31 | $111.00K S-1 · filed 2026-09-11 | |
| 2023-12-31 | $1.13M S-1 · filed 2026-09-11 | |
| 2023-09-30 | $4.78M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $4.33M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $4.90M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $19.21M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $24.55M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $30.05M 10-Q · filed 2023-08-11 | |
| 2022-03-31 | $39.77M 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $42.27M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $52.43M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $56.73M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $18.25M 10-Q · filed 2022-05-06 | |
| 2020-12-31 | $24.67M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $30.59M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $30.35M 10-Q · filed 2021-08-16 | |
| 2020-03-31 | $25.88M 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $22.49M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $22.16M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $49.33M 10-Q · filed 2020-08-07 | |
| 2019-03-31 | $44.58M 10-Q · filed 2020-05-08 | |
| 2018-12-31 | $48.61M 10-K · filed 2021-03-12 | |
| 2018-09-30 | $55.34M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $63.41M 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $18.29M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $24.05M 10-K · filed 2020-03-06 | |
| 2017-09-30 | $13.54M 10-Q · filed 2018-11-08 | $957.87K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $13.36M 10-Q · filed 2018-08-10 | $33.20K 10-K · filed 2017-10-13 |
| 2017-03-31 | $1.84M 10-Q · filed 2018-05-10 | $241.95K 10-Q · filed 2017-05-22 |
| 2016-12-31 | $2.21M 10-K · filed 2019-03-14 | $149.19K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $287.06K 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $810.81K 10-Q · filed 2017-11-14 | |
| 2016-03-31 | $1.53M 10-Q · filed 2017-05-22 | |
| 2015-12-31 | $1.37M 10-K · filed 2018-03-16 | $2.37M 10-Q · filed 2016-02-16 |
| 2015-09-30 | $3.35M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $3.33M 10-K · filed 2017-10-13 | |
| 2015-03-31 | $469.98K 10-Q · filed 2016-05-12 | |
| 2014-12-31 | $1.74M 10-K · filed 2018-03-16 | $2.11M 10-Q · filed 2015-02-17 |
| 2014-09-30 | $3.84M 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $6.11M 10-K · filed 2017-10-13 | |
| 2014-03-31 | $6.20M 10-Q · filed 2015-05-14 | |
| 2013-12-31 | $6.12M 10-Q · filed 2015-02-17 | |
| 2013-09-30 | $789.18K 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $1.60M 10-K · filed 2016-10-13 | |
| 2013-03-31 | $1.58M 10-Q · filed 2014-05-09 | |
| 2012-12-31 | $640.13K 10-Q · filed 2014-02-14 | |
| 2012-09-30 | $1.31M 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $2.00M 10-K · filed 2015-10-09 | |
| 2012-03-31 | $3.21M 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $1.55M 10-Q · filed 2013-02-14 | |
| 2011-09-30 | $2.84M 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $3.61M 10-K · filed 2014-09-29 | |
| 2011-03-31 | $4.86M 10-Q · filed 2012-05-14 | |
| 2010-12-31 | $4.84M 10-Q · filed 2012-02-14 | |
| 2010-09-30 | $6.29M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $8.03M 10-K · filed 2013-09-11 | |
| 2009-06-30 | $380.57K 10-K/A · filed 2012-10-26 | |
| 1998-06-30 | $0.00 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |